3D Structure Inspector
Structure Overview
Ligand Interactions

4FV2 - Overview - 3D Structure Inspector

Atoms
Solvent
Spheres
Surface
Colour
Opacity
Texture
Background

LeftMouse Rotate
Shift+Left Scale
Ctrl+Left Translate
Click Select
+,− Clipping
r Reset view

AstexViewer™ Copyright (C) 1999-2007 Astex Therapeutics Ltd.
OpenAstexViewer Copyright (C) 2007-2014 Mike Hartshorn





Display Compound Structure Het Het Names Het Formula
EK5
EK5
4-[4-(3-chlorophenyl)-1H-pyrazol-5-yl]-N-(2,3-dihy...
C23 H19 Cl N4 O2
EDO
1,2-Ethanediol
EDO
EGL
Ethylene Glycol
MACROGOL
Macrogol
1,2-ETHANEDIOL
C2 H6 O2
CME
CME
S,S-(2-HYDROXYETHYL)THIOCYSTEINE
C5 H11 N O3 S2
GOL
CRY
E422
GLYCERIN
GOL
Glycerin
Glycerol
Glycogelatin
Keybells
MONOCTANOIN COMPONENT D
Monoctanoin Component D
Nirolex
Ophthalgan
Optim
Osmoglyn
Procalamine
Senokot Direct Relief
Tixylix Baby
Tixylix Toddler
Waterhouse
GLYCEROL
C3 H8 O3
SO4
SO4
SUL
SULFATE ION
O4 S
PDB Code4FV2
TitleCRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5
Deposition
Release
Last Modified
ObsoleteNo
ClassificationTRANSFERASE
Experiment TypeX-RAY DIFFRACTION
Space GroupP 1 21 1
Resol Range High2
Resol Range Low55
Pubmed Id
Doi
PDB Chain4FV2_A (click to show/hide)